Molecular biology / therapeutic nucleic acids · BEGINNER LESSON

Oligonucleotide

An oligonucleotide is a short synthetic nucleic acid made of a few linked DNA or RNA units. In therapeutics, these molecules are designed to bind specific nucleic acid targets and change gene expression or protein function.

AI-assisted lesson · Public sources · Updated 2026-10-13

What it is and what is measured

An oligonucleotide is a short chain of nucleic acid building blocks. The length is usually described in nucleotides, the units that make up DNA and RNA. In drug research, oligonucleotides are measured by their sequence, length, chemical modifications, and ability to bind a target with high specificity. Therapeutic oligonucleotides include antisense oligonucleotides (ASOs), small interfering RNA (siRNA), microRNA-related molecules, aptamers, and DNAzymes. [0,1,2]

[1] Recent Advances in Oligonucleotide Therapeutics in Oncology - PMC [2] Oligonucleotide Therapeutics: From Discovery and Development to ... [3] Optimizing Oligonucleotide Therapeutics: A Model‐Informed ...

How they work

Many oligonucleotides work by Watson–Crick base pairing, which means matching bases bind each other in a predictable way. This lets them attach to a target RNA or DNA sequence. Once bound, they can trigger RNA degradation, block translation, change splicing, or in some cases activate transcription. ASOs often act on pre-mRNA or mRNA, while siRNA and related molecules can reduce gene expression through RNA-directed silencing. Aptamers are a special case: they bind targets using their three-dimensional shape rather than base pairing alone. DNAzymes are catalytic DNA molecules that can cut RNA or perform other reactions. [0,1,2]

Why chemical design matters

Unmodified oligonucleotides can be broken down quickly by nucleases, which are enzymes that cut nucleic acids. They also may enter cells poorly. To improve stability, binding, and sometimes specificity, researchers add chemical modifications to the backbone or sugar parts of the molecule. Some modifications help resist nuclease breakdown or improve plasma stability, but certain designs can also increase toxicity. Endocytosis, a cell process that brings material inside by membrane engulfment, is a main entry route for many oligonucleotides. [0,1,2]

Limitations

Oligonucleotide medicines are promising, but they face real limits. Many have poor cell penetration and limited tissue specificity. Some modified forms have hepatotoxicity, meaning liver toxicity, and some early or highly modified designs were withdrawn or used less because of safety concerns. Another challenge is that the effect inside tissues may persist even when blood levels fall, which complicates dose prediction. [0,1,2]

SEE THE IDEA

How a therapeutic oligonucleotide can act

01Designed sequence

A short DNA or RNA-like molecule is made to match a chosen target sequence.

02Target binding

Watson–Crick base pairing or shape-based recognition attaches it to RNA or another target.

03Biological effect

Binding can block translation, change splicing, promote RNA degradation, or alter transcription.

04Constraints

Delivery, stability, and toxicity can limit how well it works in the body.

A designed molecule binds a target, causes a biological change, and then faces delivery and safety limits.

Therapeutic oligonucleotides act by specific molecular recognition, but their real-world use depends on chemistry and delivery.

TRY IT YOURSELF

Test your understanding

Choose an answer, then check the explanation.

0 of 3 questions answered

01 Which statement best describes an oligonucleotide used as a drug?

02 A researcher designs a molecule that binds an mRNA and causes that RNA to be degraded. What type of action is this most consistent with?

03 A drug candidate is a short nucleic acid that binds by its 3D shape, not by matching base pairs. Which class best fits this description?

PUT IT TOGETHER

Match each concept to its meaning

Drag a label onto its description, or select a label and then select a description. This also works with a keyboard.

4 pairs to match

Sources and further reading

This general lesson was generated from public source material. It explains a concept; it does not interpret a private paper or provide medical advice.

Apply this to a paper →